Tropolones As Lead-Like Natural Products: The Development of Potent and Selective Histone Deacetylase Inhibitors
摘要:
Natural products have long been recognized as a rich source of potent therapeutics but further development is often limited by high structural complexity and high molecular weight. In contrast, at the core of the thujaplicins is a lead-like tropolone scaffold characterized by relatively low molecular weight, ample sites for diversification, and metal-binding functionality poised for targeting a range of metalloenzyme drug targets. Here, we describe the development of this underutilized scaffold for the discovery of tropolone derivatives that function as isozyme-selective inhibitors of the validated anticancer drug target, histone deacetylase (HDAC). Several monosubstituted tropolones display remarkable levels of selectivity for HDAC2 and potently inhibit the growth of T-cell lymphocyte cell lines. The tropolones represent a new chemotype of isozyme-selective HDAC inhibitors.
The furan route to tropolones: probing the antiproliferative effects of β-thujaplicin analogs
作者:E. Zachary Oblak、Erin S. D. Bolstad、Sophia N. Ononye、Nigel D. Priestley、M. Kyle Hadden、Dennis L. Wright
DOI:10.1039/c2ob26553b
日期:——
A direct route to analogs of the naturally occurring tropolone β-thujaplicin has been developed in just four steps from furan. Using this method, a series of derivatives were synthesized and evaluated. Several of these compounds demonstrated very high levels of potency against bacterial and fungal pathogens with good selectivity over mammalian cells.
On the reaction with a base (e.g., aqueous sodium hydroxide), isopropyl- and methyl-tropylium ions afforded cycloheptatrienyl polymers with an alkylene bridge, such as IIIa and IIIb, while the t-butyltropylium ion gave a mixture of 3- and 4-t-butyltropone, which was then transformed to 4-and 5-t-butyltropolone (VIIIa and IX). The bromination of VIIIa with 3 mol of bromine in methanol gave 3,7-dibromo-4-t-butyl-2-methoxy-2,3-dihydrotropolone (XIIa). On the heating of the adduct (XIIa) at 130°C, 7-bromo-4-t-butyltropolone (XIa) was formed.
Substituted tropolone compounds, oral care compositions containing the same and methods of using the same
申请人:——
公开号:US20040018216A1
公开(公告)日:2004-01-29
The present invention relates to novel tropolone compounds of the present invention and to oral care compositions suitable for preventing or treating diseases or conditions of the oral cavity in warm-blooded animals including humans, comprising an oral care effective amount of at least one novel tropolone compounds, and a pharmaceutically acceptable oral carrier. This invention further relates to a method for preventing or treating diseases or conditions of the oral cavity in warm-blooded animals including humans, by applying an oral care effective amount of the oral care composition to the oral cavity.
ORAL CARE COMPOSITIONS COMPRISING TROPOLONE COMPOUNDS AND ESSENTIAL OILS AND METHODS OF USING THE SAME
申请人:——
公开号:US20040018154A1
公开(公告)日:2004-01-29
The present invention relates to oral care compositions suitable for preventing or treating diseases or conditions of the oral cavity in warm-blooded animals including humans, comprising an oral care effective amount of at least one tropolone compound in combination with at least one essential oil, and a pharmaceutically acceptable oral carrier. This invention further relates to a method for preventing or treating diseases or conditions of the oral cavity in warm-blooded animals including humans, by applying an oral care effective amount of the oral care composition to the oral cavity.
Oral care compositions comprising tropolone compounds and essential oils and methods of using the same
申请人:——
公开号:US20040185010A1
公开(公告)日:2004-09-23
The present invention relates to oral care compositions suitable for preventing or treating diseases or conditions of the oral cavity in warm-blooded animals including humans, comprising an oral care effective amount of at least one tropolone compound in combination with at least one essential oil, and a pharmaceutically acceptable oral carrier. This invention further relates to a method for preventing or treating diseases or conditions of the oral cavity in warm-blooded animals including humans, by applying an oral care effective amount of the oral care composition to the oral cavity.